U.S. flag

An official website of the United States government

NM_000345.4(SNCA):c.44T>C (p.Val15Ala) AND Autosomal dominant Parkinson disease 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Aug 22, 2023
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003323796.3

Allele description [Variation Report for NM_000345.4(SNCA):c.44T>C (p.Val15Ala)]

NM_000345.4(SNCA):c.44T>C (p.Val15Ala)

Gene:
SNCA:synuclein alpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q22.1
Genomic location:
Preferred name:
NM_000345.4(SNCA):c.44T>C (p.Val15Ala)
HGVS:
  • NC_000004.12:g.89835624A>G
  • NG_011851.1:g.7673T>C
  • NM_000345.3:c.44T>C
  • NM_000345.4:c.44T>CMANE SELECT
  • NM_001146054.2:c.44T>C
  • NM_001146055.2:c.44T>C
  • NM_001375285.1:c.44T>C
  • NM_001375286.1:c.44T>C
  • NM_001375287.1:c.44T>C
  • NM_001375288.1:c.44T>C
  • NM_007308.3:c.44T>C
  • NP_000336.1:p.Val15Ala
  • NP_001139526.1:p.Val15Ala
  • NP_001139527.1:p.Val15Ala
  • NP_001362214.1:p.Val15Ala
  • NP_001362215.1:p.Val15Ala
  • NP_001362216.1:p.Val15Ala
  • NP_001362217.1:p.Val15Ala
  • NP_009292.1:p.Val15Ala
  • NC_000004.11:g.90756775A>G
  • NR_164674.1:n.122T>C
  • NR_164675.1:n.269T>C
Protein change:
V15A
Links:
dbSNP: rs1739238968
NCBI 1000 Genomes Browser:
rs1739238968
Molecular consequence:
  • NM_000345.4:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001146054.2:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001146055.2:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001375285.1:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001375286.1:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001375287.1:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001375288.1:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007308.3:c.44T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_164674.1:n.122T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_164675.1:n.269T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
Functional consequence:
variation affecting protein structure [Variation Ontology: 0060]

Condition(s)

Name:
Autosomal dominant Parkinson disease 1
Synonyms:
Parkinson disease 1
Identifiers:
MONDO: MONDO:0008200; MedGen: C1868595; OMIM: 168601

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004027842Institute of Neurogenetics, University of Luebeck
no assertion criteria provided
Likely pathogenic
(Aug 22, 2023)
unknown, not applicableresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providednot applicablenot applicablenot providednot providednot providednot providednot providedresearch
Turkishunknownyes1not providednot providednot providednot providedresearch

Details of each submission

From Institute of Neurogenetics, University of Luebeck, SCV004027842.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
2Turkish1not providednot providedresearchnot provided

Description

1) Generation of dopaminergic neurons: Patient skin fibroblasts carrying the p.V15A variant were reprogrammed into iPSCs using Sendai virus to deliver the four reprogramming factors OCT4, SOX2, KLF4, and cMYC (CytoTune-iPS 2.0 Sendai Reprogramming Kit, Thermo Fisher Scientific). One iPSC clone was established according to the manufacturer’s protocol and cultured on Matrigel-coated dishes (BD Biosciences) in mTeSR1 medium (STEMCELL Technologies). The line was characterized for the expression of pluripotency markers and spontaneous differentiation potential to form embryoid bodies as described previously (PMID: 30316041). A normal karyotype as well as the absence of large chromosomal aberrations was confirmed by single polymorphic nucleotide (SNP) profiling. Genome integrity was assessed by Illumina GSA-24v3.0 beadchip array and analyzed with GenomeStudio software (Illumina). iPSC lines from four control individuals (SFC084-03 (https://hpscreg.eu/cell-line/STBCi033-B), SFC086-03 (https://hpscreg.eu/cell-line/STBCi052-C), SFC089-03 (https://hpscreg.eu/cell-line/STBCi053-A), SFC156-03 (https://hpscreg.eu/cell-line/STBCi101-A) were generated and characterized previously (PMID: 28827786). The direct differentiation of iPSCs into dopaminergic neurons was conducted as described before (PMID: 28379402 ). Neurons were harvested at day 86-100 of differentiation. 2) Native Dot Blot Analysis: Total protein was extracted from cell pellets using RIPA Lysis buffer (25 mM Tris–HCl pH 7.6, 150 mM NaCl, 1% DOC, 1% NP-40, 0.1% SDS, and proteinase inhibitor cocktail). Protein extracts were used for the DC Protein Assay (Bio-Rad), and 7.5 μg of total protein extracts per sample were subjected to native dot blot analyses as previously described (PMID: 35722765). Total protein staining Revert 700 Stain Solution (Li-COR) was used as a loading control. Antibody signal intensities were normalized to the total protein. Antibodies used for the blotting analysis were as follows: primary antibody MJFR-14-6-4-2 (1:2000 #ab209538; Abcam) overnight at 4°C and secondary antibody IRDye 800CW Goat anti-Rabbit (1:20000; Li-COR) for 1h at room temperature. Detection and digitalization were performed using Odyssey CLx Infrared Imaging System (Li-COR). All the native dot blots originated from the same experiment and were processed in parallel.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not applicablenot applicablenot providednot providednot providednot providednot providednot providednot provided
2unknownyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 20, 2024